» First Patient Enrolled In Global Phase III Study Of Bevacizumab And Trastuzumab In Early Breast Cancer DrugInformations.org

« Healthcare RFID Project Rolling Out At Airedale NHS Trust - Workflow Collaboration To Streamline Use Of Vital Medical Devices, UKTaser Shock Probably Restored Man’s Heart Rhythm »

First Patient Enrolled In Global Phase III Study Of Bevacizumab And Trastuzumab In Early Breast Cancer

Jun 1st 2008Drug InformationBreast Cancer

A new international study for women with HER2-positive breast cancer is open for enrollment.

More: continued here

No Comments »

Trackback URI | Comments RSS

Leave a Reply

You must be logged in to post a comment.